Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects

Journal of Medicinal Chemistry

Volumn 49, Issue 17, 2006, Pages 5300-5308

  Klingenstein, Ralf ^a   Melnyk, Patricia ^b   Leliveld, S Rutger ^a   Ryckebusch, Adina ^b,c   Korth, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b CNRS   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; POLYQUINOLINE DERIVATIVE; PRION PROTEIN; QUINOLINE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMALARIAL ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN SCN2A; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG TARGETING; FATALITY; MALARIA; MOUSE; NONHUMAN; PATHOGENESIS; PRION DISEASE; PROTEIN FOLDING; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; CELL LINE, TUMOR; CHLOROQUINE; DRUG EVALUATION, PRECLINICAL; MICE; MOLECULAR STRUCTURE; PRIONS; QUINOLINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33747460728     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0602763     Document Type: Article

References (31)

1. Prusiner, S. B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 13363-13383.
2. Collinge, J.; Sidle, K. C. L.; Meads, J.; Ironside, J.; Hill, A. F. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996, 383, 685-690.
3. Hill, A. F.; Desbruslais, M.; Joiner, S.; Sidle, K. C. L.; Gowland, I. et al. The same prion strain causes vCJD and BSE. Nature 1997, 389, 448-450.
4. Hilton, D. A.; Ghani, A. C.; Conyers, L.; Edwards, P.; McCardle, L. et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 2004, 203, 733-739.
5. Llewelyn, C. A.; Hewitt, P. E.; Knight, R. S.; Amar, K.; Cousens, S. et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004, 363, 417-421.
6. Caughey, B.; Race, R. E. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 1992, 59, 768-771.
7. Ingrosso, L.; Ladogana, A.; Pocchiari, M. Congo red prolongs the incubation period in scrapie-infected hamsters. J. Virol. 1995, 69, 506-508.
8. Sellarajah, S.; Lekishvili, T.; Bowring, C.; Thompsett, A. R.; Rudyk, H. et al. Synthesis of analogues of Congo red and evaluation of their anti-prion activity. J. Med. Chem. 2004, 47, 5515-5534.
9. Supattapone, S.; Wille, H.; Uyechi, L.; Safar, J.; Tremblay, P. et al. Branched polyamines cure prion-infected neuroblastoma cells. J. Virol. 2001, 75, 3453-3461.
10. Yudovin-Farber, I.; Azzam, T.; Metzer, E.; Taraboulos, A.; Domb, A. J. Cationic polysaccharides as antiprion agents. J. Med. Chem. 2005, 48, 1414-1420.
11. Taraboulos, A.; Scott, M.; Semenov, A.; Avrahami, D.; Laszlo, L. et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibits formation of the scrapie isoform. J. Cell Biol. 1995, 129, 121-132.
12. Korth, C.; May, B. C. H.; Cohen, F. E.; Prusiner, S. B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9836-9841.
13. May, B. C.; Cohen, F. E.; Prusiner, S.; Korth, C. Heterotricyclic anti-prion compounds: acridines and phenothiazines. New perspectives for prion therapeutics; Edition de Conde: Paris, 2003; pp 55-70.
14. May, B. C.; Fafarman, A. T.; Hong, S. B.; Rogers, M.; Deady, L. W.; Prusiner, S.; Cohen, F. E. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3416-3421.
15. Doh-ura, K.; Iwaki, T.; Caughey, B. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 2000, 74, 4894-4897.
16. Daniel, W. A.; Bickel, M. H.; Honegger, U. E. The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues. Pharmacol. Toxicol. 1995, 77, 402-406.
17. Muhm, M.; Stimpfl, T.; Malzer, R.; Mortinger, H.; Binder, R. et al. Suicidal chloroquine poisoning: clinical course, autopsy findings, and chemical analysis. J. Forensic Sci. 1996, 41, 1077-1079.
18. Kocisko, D. A.; Baron, G. S.; Rubenstein, R.; Chen, J.; Kuizon, S. et al. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol. 2003, 77, 10288-10294.
19. Girault, S.; Grellier, P.; Berecibar, A.; Maes, L.; Lemiere, P. et al. Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers. J. Med. Chem. 2001, 44, 1658-1665.
20. Ryckebusch, A.; Deprez-Poulain, R.; Debreu-Fontaine, M. A.; Vandaele, R.; Mouray, E. et al. Parallel synthesis and anti-malarial activity of a sulfonamide library. Bioorg. Med. Chem. Lett. 2002, 12, 2595-2598.
21. Ryckebusch, A.; Deprez-Poulain, R.; Maes, L.; Debreu-Fontaine, M. A.; Mouray, E. et al. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. J. Med. Chem. 2003, 46, 542-557.
22. Carlier, P. R.; Chow, E. S.; Han, Y.; Liu, J.; El Yazal, J. et al. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions. J. Med. Chem. 1999, 42, 4225-4231.
23. Bosque, P. J.; Prusiner, S. B. Cultured cell sublines highly susceptible to prion infection. J. Virol. 2000, 74, 4377-4386.
24. Butler, D. A.; Scott, M. R. D.; Bockman, J. M.; Borchelt, D. R.; Taraboulos, A. et al. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 1988, 62, 1558-1564.
25. Peretz, D.; Williamson, R. A.; Kaneko, K.; Vergara, J.; Leclerc, E. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 2001, 412, 739-743.
26. Meshnik, S. R.; Dobson, M. J. The history of antimalarial drugs. Antimalarial Chemotherapy: mechanisms of action, resistance, and new directions in drug discovery; Humana Press: Totawa, NJ, 2001; pp 15-26.
27. Trager, W.; Jensen, J. B. Human parasites in continuous culture. Science 1976, 193, 673-677.
28. Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979, 16, 710-718.
29. Klingenstein, R.; Löber, S.; Kujala, P.; Godsave, S.; Leliveld, S. R.; Gmeiner, P.; Peters, P.; Korth, C. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J. Neurochem. 2006, 98, 748-759.
30. Haldar, K.; Mohandas, N.; Samuel, B. U.; Harrison, T.; Hiller, N. L. et al. Protein and lipid trafficking induced in erythrocytes infected by malaria parasites. Cell Microbiol. 2002, 4, 383-395.
31. Sc)-specific epitope defined by a monoclonal antibody. Nature 1997, 390, 74-77.